The Enterprise Value as of December 2025 (TTM) for OnKure Therapeutics, Inc. (OKUR) is -34012234.00

According to OnKure Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -34012234.00. This represents a change of -162.05% compared to the average of 54.81M of the last 4 quarters.

OnKure Therapeutics, Inc. (OKUR) Historical Enterprise Value (quarterly & annually)

How has OKUR Enterprise Value performed in the past?

The mean historical Enterprise Value of OnKure Therapeutics, Inc. over the last ten years is 188.79M. The current -34012234.00 Enterprise Value has changed -1901.54% with respect to the historical average. Over the past ten years (40 quarters), OKUR's Enterprise Value was at its highest in in the September 2023 quarter at 1.01B. The Enterprise Value was at its lowest in in the June 2025 quarter at -50264298.80.

OnKure Therapeutics, Inc. (OKUR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of OnKure Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

OnKure Therapeutics, Inc. (OKUR) Average Enterprise Value

How has OKUR Enterprise Value performed in the past?

The current Enterprise Value of OnKure Therapeutics, Inc. (OKUR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

OnKure Therapeutics, Inc. (OKUR) Enterprise Value vs. Peers

How is OKUR’s Enterprise Value compared to its peers?

OnKure Therapeutics, Inc.’s Enterprise Value is less than Tempest Therapeutics, Inc. (9.57M), less than Kezar Life Sciences, Inc. (20.85M), less than FibroGen, Inc. (103.14M), greater than PDS Biotechnology Corporation (-26077209422.00), greater than Xilio Therapeutics, Inc. (-57598257.00), less than Actinium Pharmaceuticals, Inc. (-7013958.00), less than Aligos Therapeutics, Inc. (26.21M), less than Mersana Therapeutics, Inc. (83.22M), less than Barinthus Biotherapeutics plc (-33263316.00), less than CEL-SCI Corporation (51.39M),

Build a custom stock screener for OnKure Therapeutics, Inc. (OKUR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OnKure Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

OnKure Therapeutics, Inc. (OKUR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like OnKure Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.